Therapeutic Innovations
Developing small molecules for neurodegenerative disease treatment through data-driven approaches.
Biomarker Research
At the core of our discovery R&D is biomarker application. Many clinical trials fail due to poor measurement in vivo of the drugs' function and effect. We integrate our target identification with biomarkers and thereby ensure we can measure target engagement throughout thedrug discovery processes.
High Throughput
Our facility uses the latest in high throughput robotics and imaging because we understand that identifying a handful of small molecules with drug-like properties is extremely challenging and hundreds of thousands of compounds need to be assessed.
Implementing high throughput screening strategies to identify potent small molecules.
Innovative Drug Discovery
We specialize in developing small molecule therapeutics for neurodegenerative diseases through data-driven approaches.
Biomarker Analysis
Utilizing biomarkers to measure target engagement for effective drug discovery and development processes.
High Throughput Screening
Employing high throughput screening strategies to identify the most active and potent small molecules.
Science drives our decisions.
Data-driven decision-making
